(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMPAKINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AMPAKINE

ST13

US500000074439919

Class

5

Filing

74439919

Registration

2157044

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

11/16/2018

Trademark type

Word

Nice classes

5

Filing date

09/24/1993

Registration date

05/12/1998

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/16/2018

Last transaction

11/16/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/29/1994

First use in commerce

12/18/1996

Drawing code

1

Owner type

03

Owner location

GLEN ROCK, NJ

Examiner

LEVINE, HOWARD

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

RESPIRERX PHARMACEUTICALS INC.
Cortex Pharmaceuticals, Inc.

Representatives

JOHN A. HUGHES Kilpatrick Townsend & Stockton LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical compositions for treatment of deficits in or improvement of memory or cognition

Publications

History of USPTO decisions and trademark events.

41 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/16/2018

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

11/16/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/16/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/16/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

11/09/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/09/2018

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/02/2010

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

03/29/2010

PRAM

POST REGISTRATION ACTION MAILED - SEC. 7

03/29/2010

ES7R

TEAS SECTION 7 REQUEST RECEIVED

03/23/2010

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/31/2008

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/31/2008

PLGL

ASSIGNED TO PARALEGAL

03/27/2008

E89R

TEAS SECTION 8 & 9 RECEIVED

03/21/2008

CFIT

CASE FILE IN TICRS

08/17/2007

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/25/2004

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

11/19/2003

R.PR

REGISTERED-PRINCIPAL REGISTER

05/12/1998

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/10/1998

DOCK

ASSIGNED TO EXAMINER

03/10/1998

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/06/1998

PCGR

PETITION TO DIRECTOR GRANTED

01/05/1998

PCRC

PETITION TO DIRECTOR RECEIVED

06/17/1997

ABN6

ABANDONMENT - NO USE STATEMENT FILED

05/19/1997

EX5M

SOU EXTENSION 5 DENIAL LETTER PREPARED

05/19/1997

EX5D

SOU EXTENSION 5 DENIAL LETTER PREPARED

05/19/1997

IUAF

USE AMENDMENT FILED

11/30/1996

EXT5

SOU EXTENSION 5 FILED

11/15/1996

EX4G

SOU EXTENSION 4 GRANTED

06/21/1996

EXT4

SOU EXTENSION 4 FILED

03/28/1996

EX3G

SOU EXTENSION 3 GRANTED

12/23/1995

EXT3

SOU EXTENSION 3 FILED

11/27/1995

EX2G

SOU EXTENSION 2 GRANTED

07/10/1995

EXT2

SOU EXTENSION 2 FILED

05/30/1995

EX1G

SOU EXTENSION 1 GRANTED

01/24/1995

EXT1

SOU EXTENSION 1 FILED

11/29/1994

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

05/31/1994

PUBO

PUBLISHED FOR OPPOSITION

03/08/1994

NPUB

NOTICE OF PUBLICATION

02/04/1994

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/10/1994

DOCK

ASSIGNED TO EXAMINER

01/08/1994

Continuous trademark protection

Get notified about every new filing that threatens AMPAKINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.